Wikidata

(Q65367960)

English

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A 12-Week Efficacy and Safety Evaluation of Budesonidel/Formoterol SPIROMAX® 160/4.5 mcg Inhalation Powder Versus SYMBICORT® TURBOHALER® 200/6 mcg in Adult and Adolescent Patients With Persistent Asthma (English)
0 references
medical condition
asthma
0 references
country
Austria
0 references
Belgium
0 references
Czech Republic
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
June 2013
0 references
end time
March 2014
0 references
number of participants
605
0 references
minimum age
12 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65367960&oldid=2237302904"